Quick Answer
Lunai Bioworks Inc. reported Stockholders Equity of -$21.35 million for fiscal year 2025.
Lunai Bioworks Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | -$21.35M | -116.2% |
| 2024 | $131.98M | +183.8% |
| 2023 | $46.50M | -36.0% |
| 2022 | $72.62M | -58.4% |
| 2021 | $174.66M | +5.0% |
| 2020 | $166.27M | -3.9% |
| 2019 | $173.10M | +9.0% |
| 2018 | $158.74M | +10256.5% |
| 2017 | $1.53M | +340.5% |
| 2016 | -$637.4K | -159.2% |
| 2015 | $1.08M | -69.1% |
| 2014 | $3.48M | +306.8% |
| 2013 | -$1.68M | -3185.0% |
| 2013 | -$51.3K | -274.8% |
| 2012 | -$13.7K | -56.6% |
| 2011 | -$8.7K | — |
| 2011 | $0.00 | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | -$13.55M | -116.5% | -3.9% |
| September 30, 2025 | -$13.04M | -113.3% | +38.9% |
| June 30, 2025 | -$21.35M | -116.2% | -124.2% |
| March 31, 2025 | $88.39M | -47.6% | +7.7% |
| December 31, 2024 | $82.06M | +88.2% | -16.3% |
| September 30, 2024 | $98.09M | +109.8% | -25.7% |
| June 30, 2024 | $131.98M | +183.8% | -21.7% |
| March 31, 2024 | $168.60M | +155.0% | +286.7% |
- Lunai Bioworks Inc. showed a decrease of -116.2% in Stockholders Equity compared to the prior fiscal year.
- The most recent figure is from Lunai Bioworks Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on September 29, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: